JPRN-UMIN000021949尚未招募1 期
A phase I trial of biweekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancer - Biweekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patient with allergy of paclitaxel or ramucirumab 2)patient with contraindication for paclitaxel or ramucirumab 3)patient who had previously administered with paclitaxel as first line therapy 4)patient who has a serious infection 5)patient who has serious complications such as heart disease, respitary disorder, cerebrovascular disorder, liver disease and much ascites or pleural effusion 6)patient who has recieved chemotherapy within 2weeks 7)patient who has recieved therapy with blood products 8)patient with other malignat tumor 9)patient with neuropathy (>=grade 2) 10)patient with urinary protein (>=grade 2) 11)patient with brain symptomatic metastasis 12)patient who recieved with steroid 13)patient with psychic disorder 14)patient with pregnancy, lactating or possibility of pregnancy 15)patient who given a dicision of unsuitable for this study by the investigator
研究者
相似试验
已完成
1 期
Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer (NJLCG1402)on-small cell lung cancerJPRN-UMIN000014893orth Japan Lung Cancer Study Group (NJLCG)42
已完成
1 期
Phase I trial of weekly nab-paclitaxel plus cyclophosphamide for metastatic breast canceradvanced or metastatic breast cancerJPRN-UMIN000010945Mitsui Memorial Hospital Department of Breast Endocrine Surgery9
招募中
1 期
A phase II study of weekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancergastric cancerJPRN-UMIN000031285Department of Gastroenterological, Breast and Endocrine Surgery,Yamaguchi University Graduate School of Medicine46
招募中
不适用
Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Breast CancerBreast cancerJPRN-UMIN000005979Wakayama Medical University50
已完成
2 期
Phase II study of weekly nab-paclitaxel in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy.JPRN-UMIN000013390ational Hospital Organization Asahikawa Medical center40